The FDA has approved Bristol Myers Squibb’s combination therapy for colorectal cancer patients with certain genetic mutations, marking a significant…
Browsing: Hot headlines in GI
Europe has recently approved Fruzaqla for the treatment of metastatic colorectal cancer, bringing new hope to patients battling this aggressive…
Key Insights The FDA clearance of this gastrointestinal parasite detection kit marks a significant advancement in diagnostic capabilities, promising improved…
Key Insights The disenrollment of millions from Medicaid presents both challenges and opportunities for ASCs. By staying informed, adapting strategies,…
Key Insights The anticipation surrounding AbbVie’s Skyrizi reflects its potential to significantly enhance the treatment landscape for ulcerative colitis. Gastroenterologists…
The study indicates that GLP-1 medications, with proper precautions, can be safely continued before surgical procedures. This calls for updated…
Key Insights: The primary challenges faced by gastroenterologists include navigating regulatory complexities, securing fair reimbursements from insurers, and managing long…
Key Insights: Addressing smoke inhalation risks in endoscopy suites is vital for healthcare worker safety. Implementing effective safety measures and…
Key Insights: Transoral Incisionless Fundoplication represents a significant advancement in gastroenterology, providing an effective, safe, and minimally invasive treatment for…
Key Insights: